Results 241 to 250 of about 1,397,619 (300)
Some of the next articles are maybe not open access.
Current Infectious Disease Reports, 2008
Aerobic gram-negative bacilli are rare causes of endocarditis. The epidemiology and risk factors for developing gram-negative endocarditis are evolving. New pathogens, some of which are multidrug resistant, are emerging. The role of nosocomial infections, particularly central venous catheter infections, is increasing.
Milagros P, Reyes, Katherine C, Reyes
openaire +2 more sources
Aerobic gram-negative bacilli are rare causes of endocarditis. The epidemiology and risk factors for developing gram-negative endocarditis are evolving. New pathogens, some of which are multidrug resistant, are emerging. The role of nosocomial infections, particularly central venous catheter infections, is increasing.
Milagros P, Reyes, Katherine C, Reyes
openaire +2 more sources
Radiology, 1973
Abstract The chest films of 58 patients with proved pneumonia due to Pseudomonas, Klebsiella, Enterobacter, Escherichia coli, Proteus, or Bacteroides were reviewed. Pseudomonas pneumonia was characterized by diffuse alveolar involvement with rapid progression to extensive macrocavitation.
J D, Unger, H D, Rose, G F, Unger
openaire +2 more sources
Abstract The chest films of 58 patients with proved pneumonia due to Pseudomonas, Klebsiella, Enterobacter, Escherichia coli, Proteus, or Bacteroides were reviewed. Pseudomonas pneumonia was characterized by diffuse alveolar involvement with rapid progression to extensive macrocavitation.
J D, Unger, H D, Rose, G F, Unger
openaire +2 more sources
1975
Die Gram-negative Follikulitis (eigentlich sollte es heisen: Follikulitis durch Gram-negative Keime, aber der Terminus hat sich so eingeburgert, das wir ihn belassen wollen) wurde erstmals 1968 bei einer Gruppe Patienten mit langjahriger therapierefraktarer Acne vulgaris beschrieben.
Gerd Plewig, Albert M. Kligman
openaire +1 more source
Die Gram-negative Follikulitis (eigentlich sollte es heisen: Follikulitis durch Gram-negative Keime, aber der Terminus hat sich so eingeburgert, das wir ihn belassen wollen) wurde erstmals 1968 bei einer Gruppe Patienten mit langjahriger therapierefraktarer Acne vulgaris beschrieben.
Gerd Plewig, Albert M. Kligman
openaire +1 more source
Gram-negative bloodstream infections
International Journal of Antimicrobial Agents, 2009Gram-negative bloodstream infection (BSI) is both dangerous and challenging. The incidence of Gram-negative BSI rises with age in both men and women, but there are still some gender differences in terms of aetiology and acquisition. Clinical elements such as organ dysfunction are helpful in determining prognosis.
Martin E, Stryjewski, Helen W, Boucher
openaire +2 more sources
Resistant Gram-Negative Infections
Critical Care Clinics, 2013This article reviews the global crisis of resistant gram-negative bacilli in the intensive care unit. The authors discuss drugs used for treating these infections and the different strategies used to maximize the effect of antimicrobials.
Henry, Fraimow, Raquel, Nahra
openaire +2 more sources
Supportive Care in Cancer, 1993
In the 1960s, almost all patients who developed gram-negative bacteremia during granulocytopenia died; death occurred before blood culture results were available in about 50% of cases; many patients received antibiotics that were, at best, suboptimal and frequently inactive against the invading pathogen.
openaire +2 more sources
In the 1960s, almost all patients who developed gram-negative bacteremia during granulocytopenia died; death occurred before blood culture results were available in about 50% of cases; many patients received antibiotics that were, at best, suboptimal and frequently inactive against the invading pathogen.
openaire +2 more sources
Gram-negative Bacillary Meningitis
Medical Clinics of North America, 1985The incidence of gram-negative bacillary meningitis has increased significantly in the past two decades. Approximately two thirds of all reported cases have occurred after neurosurgical procedures. With the development of the newer cephalosporins, the overall mortality rate has decreased from 40 to 80 per cent to 10 to 20 per cent.
J L, LeFrock, B R, Smith, A, Molavi
openaire +2 more sources